• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  T cell receptor (TCR) peptide (BV5S2, BV6S5, BV13S1) vaccine
Trade Name:  Neurovax
Date Designated:  02/06/2014
Orphan Designation:  Treatment of Pediatric Multiple Sclerosis
Orphan Designation Status:  Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Marketing Approval Date:  N/A
Approved Labeled Indication:  
Exclusivity End Date:    N/A
Immune Response BioPharma, Inc.
244 5th Avenue
Suite 1727
New York 10001
USA

The sponsor address listed is the last reported by the sponsor to OOPD.
-
-